Caption Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-403,200
| Closed | -$40.9M | – | 1685 |
|
|
2025
Q4 | $40.9M | Buy |
403,200
+355,100
| +738% | +$28.5M | 0.28% | 77 |
|
|
2025
Q3 | $2.63M | Sell |
48,100
-28,400
| -37% | -$1.42M | 0.02% | 734 |
|
|
2025
Q2 | $4.07M | Buy |
+76,500
| New | +$3.89M | 0.05% | 462 |
|
|
2025
Q1 | – | Sell |
-521,700
| Closed | -$29.3M | – | 1674 |
|
|
2024
Q4 | $29.3M | Buy |
+521,700
| New | +$32.5M | 0.28% | 49 |
|
|
2024
Q2 | – | Sell |
-325,400
| Closed | -$22.5M | – | 1265 |
|
|
2024
Q1 | $22.5M | Buy |
325,400
+246,000
| +310% | +$15.6M | 0.34% | 56 |
|
|
2023
Q4 | $5.87M | Buy |
79,400
+35,300
| +80% | +$2.31M | 0.08% | 290 |
|
|
2023
Q3 | $3.01M | Sell |
44,100
-105,100
| -70% | -$8.92M | 0.05% | 479 |
|
|
2023
Q2 | $14M | Buy |
149,200
+124,200
| +497% | +$9.69M | 0.25% | 96 |
|
|
2023
Q1 | $1.7M | Sell |
25,000
-218,200
| -90% | -$14M | 0.03% | 490 |
|
|
2022
Q4 | $12M | Buy |
+243,200
| New | +$9.94M | 0.19% | 133 |
|
|
2022
Q3 | – | Sell |
-500
| Closed | -$20K | – | 1604 |
|
|
2022
Q2 | $20K | Sell |
500
-130,000
| -100% | -$6.95M | ﹤0.01% | 1369 |
|
|
2022
Q1 | $9.13M | Buy |
130,500
+61,500
| +89% | +$4.5M | 0.11% | 245 |
|
|
2021
Q4 | $5.37M | Buy |
+69,000
| New | +$6.09M | 0.06% | 432 |
|
|
2021
Q1 | – | Sell |
-93,600
| Closed | -$12.4M | – | 1150 |
|
|
2020
Q4 | $12.4M | Buy |
93,600
+83,600
| +836% | +$10.1M | 0.28% | 89 |
|
|
2020
Q3 | $1.02M | Hold |
10,000
| – | – | 0.02% | 610 |
|
|
2020
Q2 | $869K | Sell |
10,000
-28,600
| -74% | -$2.29M | 0.03% | 567 |
|
|
2020
Q1 | $2.24M | Sell |
38,600
-232,900
| -86% | -$18.9M | 0.13% | 226 |
|
|
2019
Q4 | $25.1M | Buy |
271,500
+146,500
| +117% | +$12.9M | 0.84% | 16 |
|
|
2019
Q3 | $11.3M | Buy |
125,000
+75,000
| +150% | +$8.55M | 0.59% | 34 |
|
|
2019
Q2 | $5.9M | Sell |
50,000
-43,000
| -46% | -$4.33M | 0.3% | 92 |
|
|
2019
Q1 | $8.06M | Sell |
93,000
-36,100
| -28% | -$3.07M | 0.44% | 59 |
|
|
2018
Q4 | $8.15M | Buy |
129,100
+104,100
| +416% | +$7.14M | 0.65% | 33 |
|
|
2018
Q3 | $1.97M | Hold |
25,000
| – | – | 0.11% | 229 |
|
|
2018
Q2 | $1.49M | Hold |
25,000
| – | – | 0.12% | 203 |
|
|
2018
Q1 | $1.01M | Sell |
25,000
-175,000
| -88% | -$8.54M | 0.14% | 154 |
|
|
2017
Q4 | $10.5M | Buy |
+200,000
| New | +$10.7M | 1.09% | 24 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Caption Management's EXAS Position: Q1 2026 in Review
Caption Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 170,679 shares — an estimated $17.3M sold.
Caption Management first reported a position in EXAS in Q4 2018 and held it in 14 quarters. The position peaked at $17.3M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Caption Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Caption Management sold 170,679 Exact Sciences shares in Q1 2026, an estimated $17.3M.
- Caption Management first reported a position in Exact Sciences in Q4 2018 and held it in 14 quarters.
- Caption Management's Exact Sciences position peaked at $17.3M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.